scholarly journals Approaches to the Diagnosis and Management of Ovarian Cancer in Pregnancy

2021 ◽  
Vol Volume 13 ◽  
pp. 2329-2339
Author(s):  
Kaja Michalczyk ◽  
Aneta Cymbaluk-Płoska
Keyword(s):  
Ovarian Cancer ◽  
Diagnosis And Management ◽  
Cancer In Pregnancy ◽  
In Pregnancy

scholarly journals P11.09: A case of mature teratoma with strumal foci mimicking borderline ovarian cancer in pregnancy

2017 ◽  
Vol 50 ◽  
pp. 189-190
Author(s):  
R. Heremans ◽  
W. Froyman ◽  
C. Landolfo ◽  
S. Han ◽  
P. Moerman ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Mature Teratoma ◽  
Cancer In Pregnancy ◽  
Borderline Ovarian Cancer ◽  
In Pregnancy

Cancer in pregnancy: To treat or not?

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. e12533-e12533
Author(s):  
Elaine Walsh ◽  
Grainne O'Kane ◽  
Karen Anne Cadoo ◽  
Donna M. Graham ◽  
Grzegorz Korpanty ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Post Partum ◽  
In Utero ◽  
Adverse Outcomes ◽  
Cytotoxic Agents ◽  
Normal Delivery ◽  
Cancer In Pregnancy ◽  
Disease Free ◽  
In Pregnancy

e12533 Background: Cancer in pregnancy accounts for ~1 in 1,000 pregnancies. Studies show that cytotoxic agents are safe from the second trimester. Long-term follow up has not shown increased malformations or malignancies in children exposed to chemotherapy in utero. There is no evidence of worse outcomes among women diagnosed in pregnancy. Methods: We retrospectively identified women diagnosed with cancer in pregnancy over a 25-year period. Medical records were reviewed for demographics, diagnosis, gestation, timing of treatment and outcomes. We assessed if all cancers need to be treated in pregnancy or if treatment could be safely deferred to allow normal delivery. Results: Twenty-five women were diagnosed with cancer in pregnancy and referred to medical oncology. Of 25 women, 16 (64%) received chemotherapy during pregnancy. These included 13 cases of breast cancer, one Ewing’s sarcoma, one ovarian cancer, and one small cell of cervix. All 16 women received doxorubicin and cyclophosphamide. There were 15 live births and no abnormalities seen in children who received chemotherapy in utero. At a median follow-up of 6 years 11 mothers (69%) are disease free and 4 (25%) have recurrent disease. Of nine mothers who did not receive chemotherapy in pregnancy, seven received chemotherapy immediately post-partum. Six (86%) were diagnosed in early pregnancy (median gestation 13 weeks). There were three cases of Hodgkin lymphoma, two breast cancers, and one ovarian cancer. At a median follow-up of 12 years, all mothers remain disease free. There were no abnormalities seen in these children. Conclusions: We did not identify any adverse outcomes in mothers or infants exposed to chemotherapy during pregnancy. We identified a cohort of patients that do not need immediate treatment during pregnancy. In selected cases, it is safe and appropriate to delay chemotherapy until delivery of the baby. There were no adverse outcomes to mothers due to delayed treatment and no adverse outcomes to babies not exposed to chemotherapy in utero. A multi-disciplinary team is essential to individualize treatment planning. [Table: see text]

A case of early-stage epithelial ovarian cancer in pregnancy

2001 ◽  
Vol 11 (5) ◽  
pp. 413-417 ◽  
Author(s):  
G. Otton ◽  
S. Higgins ◽  
K. A. Phillips ◽  
M. Quinn
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Early Stage ◽  
Cancer In Pregnancy ◽  
In Pregnancy

Decidualized Endometrioma Masquerading as Ovarian Cancer in Pregnancy

2014 ◽  
Vol 33 (11) ◽  
pp. 1909-1915 ◽  
Author(s):  
Yvette Groszmann ◽  
Brooke E. Howitt ◽  
Bryann Bromley ◽  
Colleen M. Feltmate ◽  
Beryl R. Benacerraf
Keyword(s):  
Ovarian Cancer ◽  
Cancer In Pregnancy ◽  
In Pregnancy

scholarly journals Spontaneous rupture of malignant ovarian cyst in 8-gestation-week pregnancy: A case report and literature review

2011 ◽  
Vol 19 (1-2) ◽  
pp. 39-41 ◽  
Author(s):  
Ljiljana Mladenovic-Segedi ◽  
Aljosa Mandic ◽  
Dimitrije Segedi ◽  
Tatjana Kozarcic
Keyword(s):  
Ovarian Cancer ◽  
Histopathological Examination ◽  
Post Partum ◽  
Cystic Tumor ◽  
Medical Observation ◽  
Healthy Female ◽  
Good General Condition ◽  
Cancer In Pregnancy ◽  
Gestational Week ◽  
In Pregnancy

Ovarian cancer takes the second place in the incidence of all genital carcinomas occurring in pregnancy. In spite of a low overall incidence of ovarian cancer in pregnancy and, in most cases, asymptomatic clinical picture, the routine use of ultrasonographic examination in early pregnancy has led to a more frequent detection of adnexal masses in pregnant women. The authors presented a case of a 35-years-old patient with the diagnosis of unilocular cyst in the left ovary detected by ultrasonography at gestational week 8, with the subsequent sinistral adnexectomy administered for the rupture of the cystic tumor. Based on the histopathological examination we established the diagnosis of a serous cystadenocarcinoma stage I. The patient refused any proposed modality of oncologic diagnostics and therapy, and delivered a healthy female newborn of 3630g/49 cm, 10 days after the probable term of delivery. The control MRI, 8 months post partum did not confirm the presence of any pathological changes of either genital organs or any other organ of the small pelvis. The patient is in good general condition, under continual medical observation.

Cisplatinum and docetaxel for ovarian cancer in pregnancy

2009 ◽  
Vol 280 (5) ◽  
pp. 823-825 ◽  
Author(s):  
Abdulrahim A. Rouzi ◽  
Nora N. Sahly ◽  
Naif F. Sahly ◽  
Mahmoud S. Alahwal
Keyword(s):  
Ovarian Cancer ◽  
Cancer In Pregnancy ◽  
In Pregnancy

Ovarian cancer in pregnancy

2017 ◽  
Vol 41 ◽  
pp. 108-117 ◽  
Author(s):  
Robert Fruscio ◽  
Jorine de Haan ◽  
Kristel Van Calsteren ◽  
Magali Verheecke ◽  
Mina Mhallem ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer In Pregnancy ◽  
In Pregnancy
Sign in / Sign up

Export Citation Format

Share Document